- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | ENvue Medical receives patent allowance for feeding tube technology | 3 | Investing.com | ||
| Di | ENvue Medical, Inc.: ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera | 3 | GlobeNewswire (USA) | ||
| 04.02. | Morning Market Movers: Silicon Laboratories, Concorde International Group, ENvue Medical, Enphase Energy See Big Swings | 398 | AFX News | SUNNYVALE (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 30.01. | ENvue Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 28.01. | ENvue Medical partners with U-Deliver to distribute ENFit syringes | 8 | Investing.com | ||
| 28.01. | ENvue Medical, Inc.: ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line | 8 | GlobeNewswire (USA) | ||
| 28.01. | EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal | 10 | Benzinga.com | ||
| 21.01. | ENvue Medical, Inc.: ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial | 4 | GlobeNewswire (USA) | ||
| 14.01. | ENvue Medical, Inc.: ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription | 5 | GlobeNewswire (USA) | ||
| 14.01. | EXCLUSIVE: Micro-Cap ENvue Medical Launches OTC Reusable Syringes For Feeding, Medication Delivery | 10 | Benzinga.com | ||
| 09.01. | ENvue Medical to develop vibration tech for nasogastric tube comfort | 2 | Investing.com | ||
| 09.01. | ENvue Medical, Inc.: ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research | 3 | GlobeNewswire (USA) | ||
| 08.01. | ENvue Medical, Inc.: ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 | 4 | GlobeNewswire (USA) | ||
| 30.12.25 | Envue Medical passt langfristigen Anreizplan an israelisches Steuerrecht an | 11 | Investing.com Deutsch | ||
| 23.12.25 | ENvue Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.12.25 | UK adds ENvue Medical's UroShield kit to NHS drug tariff | 3 | Investing.com | ||
| 18.12.25 | ENvue Medical, Inc.: ENvue Medical, Formerly NanoVibronix, UroShield Kit Secures Reimbursement in the UK | 2 | GlobeNewswire (USA) | ||
| 12.12.25 | NanoVibronix feeds into new focus on ENvue enteral system with rebrand | 4 | FiercePharma | ||
| 12.12.25 | NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol | 3 | Investing.com | ||
| 12.12.25 | NanoVibronix, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,140 | -0,59 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| BECTON DICKINSON | 150,30 | +0,64 % | BD (Becton, Dickinson and Company): Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase | FRANKLIN LAKES, N.J., Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,017 | -6,59 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| SPINEWAY | 0,166 | -0,84 % | Spineway: 2025 annual results | Ecully, February 17, 2026 - 7:00 p.m. SPINEWAY2025 annual results Revenue up 4%Improved resultsStronger growth potential Condensed consolidated income statement20252024Pro forma* 2024ReportedIn thousands... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 7,400 | +14,37 % | Lifeward Ltd.: Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors | IP and technology acquisition is expected to be highly accretive and to advance Lifeward's position as a diversified biomedical innovation companyWill Expand Lifeward's portfolio beyond lower-limb... ► Artikel lesen | |
| NUWELLIS, INC | 1,510 | -6,21 % | Nuwellis, Inc. - 8-K, Current Report | ||
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| GLUCOTRACK | 1,570 | -3,09 % | Glucotrack, Inc.: Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform | RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization... ► Artikel lesen | |
| BONE BIOLOGICS | 1,160 | 0,00 % | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| MANGOCEUTICALS | 0,530 | +3,80 % | Mangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study | Dallas, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine... ► Artikel lesen | |
| FRESENIUS | 50,90 | -0,82 % | Mehr Dividende, mehr Gewinn: Darum kann Fresenius nicht punkten | Die Fresenius Aktie steht zu Beginn des Handelstages unter Abgabedruck: Auch wenn die Pharmasparte Kabi und das Krankenhausgeschäft gut laufen und dem DAX-Konzern für 2025 zu soliden Ergebnissen verholfen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,220 | -5,83 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,470 | +0,64 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GERRESHEIMER | 16,950 | +7,96 % | Gerresheimers Abschluss unter dem Röntgenblick der BaFin | Die BaFin verschärft den Blick auf die Rechnungslegung der Gerresheimer AG. Sie kündigt an, die am 18.09.2025 gestartete Anlassprüfung des offengelegten Konzernabschlusses und Konzernlageberichts 2023/2024... ► Artikel lesen |
Das Unternehmen ENVUE MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,195 (-8,65 %) liegt der Kurs bei 2,060 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.